Alnylam Pharmaceuticals, Inc. <ALNY.O>: Wells Fargo cuts target price to $316 from $377
ALNY•Related News
ExxonMobil Says Not Done Yet in Guyana, Continues To See a Bright Future There
XOM•
Three Fed dissenters say rate hike is needed to curb inflation
TLT•
Security Federal Q2 FY26 net income available to common shareholders rises 55.4% to $3.7 million; EPS climbs to $1.19
SFDL•
Callan JMB files draft information statement on Nasdaq 20% issuance approval
CJMB•
Nasdaq Trade Halt <MGRX.O> Volatility Trading Pause at 10:22 AM
MGRX•